Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40015513
Localisation
Japan
Asia
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
03/06/2021
Statut
Classification
1.5°C
Année cible
FY2031
SHIONOGI commits to reduce absolute scope 1 and 2 GHG emissions 46.2% by FY2030/31 from a FY2019/20 base year. SHIONOGI commits to reduce absolute scope 3 GHG emissions from purchased goods and services 20% by FY2030/31 from a FY2019/20 base year.
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
JP3347200002
LEI
35380049VXDTHZI3DY35
Source : Science Based Targets initiative | Données publiques